Literature DB >> 12368448

Temperature-induced changes in the cell-wall components of Mycobacterium thermoresistibile.

Laurent Kremer1, Yann Guérardel, Sudagar S Gurcha, Camille Locht, Gurdyal S Besra.   

Abstract

The mycobacterial cell wall consists of a core composed of peptidoglycan linked to the heteropolysaccharide arabinogalactan, which in turn is attached to mycolic acids. A variety of free lipids complements the mycolyl residues, whereas phosphatidylinositol mannosides (PIMs), lipoarabinomannan and proteins are interspersed in this framework. As a consequence, the cell envelope is extremely rich in lipids and early work has shown that the lipid content may vary with environmental conditions. To extend these studies, the influence of growth temperature on cell envelope components in Mycobacterium thermoresistibile, a temperature-resistant mycobacterial species, was investigated. Mycolic acid synthesis was reduced at 55 degrees C compared to 37 degrees C and the production of fatty acids, presumably precursors of mycolic acids, was increased. Since fatty acids are elongated by the type II fatty acid synthase complex and consequently by a mycobacterial beta-ketoacyl acyl carrier protein synthase (KasA), leading to mycolic acids, the expression level of KasA was analysed by Western blotting. KasA expression was significantly decreased at 55 degrees C over 37 degrees C. Important changes in the mycolic acid composition were observed and characterized by reduced levels of cyclopropanation and the concomitant accumulation of the cis-olefin derivatives. In addition, striking differences involved in complex lipid composition, including acylated trehaloses and trehalose dimycolate (TDM) were also observed. At 55 degrees C, M. thermoresistibile produced less TDM than at 37 degrees C, which could be explained by the down-regulation of antigen 85 (Ag85) expression as shown by Western blotting. The Ag85 complex represents a family of proteins known to catalyse the transfer of mycolates to trehalose, thereby generating TDM. Furthermore, at 55 degrees C the level of phosphatidyl-inositol hexamannoside (PIM(6)) synthesis, but not that of other PIM species, was dramatically reduced. This observation could be correlated to a decrease of mannosyltransferase activity associated with membranes prepared from cells grown at 55 degrees C as compared to 37 degrees C. Altogether, this study suggests that mycobacteria are capable of inducing important cell-wall changes in response to temperature variations, which may represent a strategy developed by the bacteria to adapt to environmental changes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12368448     DOI: 10.1099/00221287-148-10-3145

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  29 in total

1.  Temperature-dependent regulation of mycolic acid cyclopropanation in saprophytic mycobacteria: role of the Mycobacterium smegmatis 1351 gene (MSMEG_1351) in CIS-cyclopropanation of alpha-mycolates.

Authors:  Laeticia Alibaud; Anuradha Alahari; Xavier Trivelli; Anil K Ojha; Graham F Hatfull; Yann Guerardel; Laurent Kremer
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

2.  Environmental stress and antibiotic resistance in food-related pathogens.

Authors:  M Ann S McMahon; Jiru Xu; John E Moore; Ian S Blair; David A McDowell
Journal:  Appl Environ Microbiol       Date:  2006-12-01       Impact factor: 4.792

3.  Exposure of mycobacteria to cell wall-inhibitory drugs decreases production of arabinoglycerolipid related to Mycolyl-arabinogalactan-peptidoglycan metabolism.

Authors:  Yoann Rombouts; Belinda Brust; Anil K Ojha; Emmanuel Maes; Bernadette Coddeville; Elisabeth Elass-Rochard; Laurent Kremer; Yann Guerardel
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

4.  Antimycobacterial Activity and Mechanism of Action of NAS-91.

Authors:  Paul Gratraud; Namita Surolia; Gurdyal S Besra; Avadhesha Surolia; Laurent Kremer
Journal:  Antimicrob Agents Chemother       Date:  2007-12-17       Impact factor: 5.191

5.  Cyclipostins and cyclophostin analogs inhibit the antigen 85C from Mycobacterium tuberculosis both in vitro and in vivo.

Authors:  Albertus Viljoen; Matthias Richard; Phuong Chi Nguyen; Patrick Fourquet; Luc Camoin; Rishi R Paudal; Giri R Gnawali; Christopher D Spilling; Jean-François Cavalier; Stéphane Canaan; Mickael Blaise; Laurent Kremer
Journal:  J Biol Chem       Date:  2018-01-04       Impact factor: 5.157

6.  AccD6, a key carboxyltransferase essential for mycolic acid synthesis in Mycobacterium tuberculosis, is dispensable in a nonpathogenic strain.

Authors:  Jakub Pawelczyk; Anna Brzostek; Laurent Kremer; Bozena Dziadek; Anna Rumijowska-Galewicz; Marta Fiolka; Jaroslaw Dziadek
Journal:  J Bacteriol       Date:  2011-10-07       Impact factor: 3.490

7.  Ergothioneine is a secreted antioxidant in Mycobacterium smegmatis.

Authors:  Carine Sao Emani; Monique J Williams; Ian J Wiid; Nicholas F Hiten; Albertus J Viljoen; Ray-Dean D Pietersen; Paul D van Helden; Bienyameen Baker
Journal:  Antimicrob Agents Chemother       Date:  2013-04-29       Impact factor: 5.191

8.  The DosR dormancy regulator of Mycobacterium tuberculosis stimulates the Na(+)/K (+) and Ca (2+) ATPase activities in plasma membrane vesicles of mycobacteria.

Authors:  Paola A Pulido; Lorena Novoa-Aponte; Nicolás Villamil; Carlos Y Soto
Journal:  Curr Microbiol       Date:  2014-06-18       Impact factor: 2.188

9.  Possible association of GroES and antigen 85 proteins with heat resistance of Mycobacterium paratuberculosis.

Authors:  Nackmoon Sung; Kuni Takayama; Michael T Collins
Journal:  Appl Environ Microbiol       Date:  2004-03       Impact factor: 4.792

10.  Oleic acid biosynthesis in Plasmodium falciparum: characterization of the stearoyl-CoA desaturase and investigation as a potential therapeutic target.

Authors:  Paul Gratraud; Enlli Huws; Brie Falkard; Sophie Adjalley; David A Fidock; Laurence Berry; William R Jacobs; Mark S Baird; Henri Vial; Laurent Kremer
Journal:  PLoS One       Date:  2009-09-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.